FDA Approved: TIGLUTIK — Supplemental Application (EDW PHARMA, INC)

View source ↗

Summary

FDA approved a supplemental application for TIGLUTIK (riluzole) filed by EDW PHARMA, INC, resulting in approved labeling changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• TIGLUTIK (RILUZOLE)

Snippet

SUPPL AP for TIGLUTIK (RILUZOLE)